4-23834777-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_013261.5(PPARGC1A):​c.235-3026G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.638 in 151,904 control chromosomes in the GnomAD database, including 30,945 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.64 ( 30945 hom., cov: 31)

Consequence

PPARGC1A
NM_013261.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.530

Publications

9 publications found
Variant links:
Genes affected
PPARGC1A (HGNC:9237): (PPARG coactivator 1 alpha) The protein encoded by this gene is a transcriptional coactivator that regulates the genes involved in energy metabolism. This protein interacts with PPARgamma, which permits the interaction of this protein with multiple transcription factors. This protein can interact with, and regulate the activities of, cAMP response element binding protein (CREB) and nuclear respiratory factors (NRFs). It provides a direct link between external physiological stimuli and the regulation of mitochondrial biogenesis, and is a major factor that regulates muscle fiber type determination. This protein may be also involved in controlling blood pressure, regulating cellular cholesterol homoeostasis, and the development of obesity. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_013261.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.686 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_013261.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPARGC1A
NM_013261.5
MANE Select
c.235-3026G>A
intron
N/ANP_037393.1Q9UBK2-1
PPARGC1A
NM_001330751.2
c.250-3026G>A
intron
N/ANP_001317680.1Q9UBK2-3
PPARGC1A
NM_001354825.2
c.250-3026G>A
intron
N/ANP_001341754.1Q9UBK2-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPARGC1A
ENST00000264867.7
TSL:1 MANE Select
c.235-3026G>A
intron
N/AENSP00000264867.2Q9UBK2-1
PPARGC1A
ENST00000613098.4
TSL:1
c.-147-3026G>A
intron
N/AENSP00000481498.1Q9UBK2-9
PPARGC1A
ENST00000506055.5
TSL:1
n.235-3026G>A
intron
N/AENSP00000423075.1Q9UBK2-2

Frequencies

GnomAD3 genomes
AF:
0.638
AC:
96866
AN:
151786
Hom.:
30915
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.610
Gnomad AMI
AF:
0.588
Gnomad AMR
AF:
0.697
Gnomad ASJ
AF:
0.675
Gnomad EAS
AF:
0.521
Gnomad SAS
AF:
0.601
Gnomad FIN
AF:
0.647
Gnomad MID
AF:
0.690
Gnomad NFE
AF:
0.650
Gnomad OTH
AF:
0.657
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.638
AC:
96949
AN:
151904
Hom.:
30945
Cov.:
31
AF XY:
0.637
AC XY:
47291
AN XY:
74206
show subpopulations
African (AFR)
AF:
0.610
AC:
25273
AN:
41414
American (AMR)
AF:
0.697
AC:
10653
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.675
AC:
2338
AN:
3466
East Asian (EAS)
AF:
0.520
AC:
2683
AN:
5160
South Asian (SAS)
AF:
0.601
AC:
2895
AN:
4814
European-Finnish (FIN)
AF:
0.647
AC:
6799
AN:
10514
Middle Eastern (MID)
AF:
0.687
AC:
202
AN:
294
European-Non Finnish (NFE)
AF:
0.650
AC:
44179
AN:
67940
Other (OTH)
AF:
0.659
AC:
1391
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1840
3679
5519
7358
9198
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
798
1596
2394
3192
3990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.655
Hom.:
4049
Bravo
AF:
0.641
Asia WGS
AF:
0.615
AC:
2138
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.9
DANN
Benign
0.49
PhyloP100
0.53
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4697046;
hg19: chr4-23836400;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.